4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Gland Pharma Limited (GLAND) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India with about 4,332 employees. Its market capitalization is roughly ₹506 billion. In the fiscal year ended 2026-03-31, GLAND reported ₹64.0B in revenue and ₹10.3B in net income.
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
Interactive charts & full statements → Open the GLAND valuation workbench →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹64.0B | ₹55.8B | ₹56.4B | ₹35.9B |
| Gross Profit | ₹41.6B | ₹34.9B | ₹34.7B | ₹19.1B |
| Operating Income (EBIT) | ₹12.1B | ₹8.9B | ₹10.0B | ₹8.7B |
| Net Income | ₹10.3B | ₹7.0B | ₹7.7B | ₹7.8B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹18.0B | ₹17.4B | ₹17.0B | ₹15.1B | ₹14.2B |
| Gross Profit | ₹11.8B | ₹11.5B | ₹11.2B | ₹9.8B | ₹9.4B |
| Operating Income (EBIT) | ₹3.8B | ₹4.0B | ₹3.3B | ₹2.7B | ₹2.5B |
| Net Income | ₹3.2B | ₹3.7B | ₹2.6B | ₹2.2B | ₹1.9B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹3.0B) | (₹3.3B) | — | — | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹125.1B | ₹112.2B | ₹106.6B | ₹87.8B | — |
| Total Liabilities | ₹21.5B | ₹20.7B | ₹19.4B | ₹8.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GLAND viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms